LivaNova PLC (LIVN)

CIK 0001639691 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

Sector Manufacturing
Incorporated X0
Fiscal year ends Dec 31

For the year ended 2025-12-31, LivaNova PLC reported revenue of $1.39B. Revenue grew 10.7% from the prior annual period.

Key ratios (year ended 2025-12-31)

67.7%

Gross margin

14.4%

Operating margin

-17.5%

Net margin

-20.2%

Return on year-end equity

10.7%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-09-02

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$1.39B	$1.25B	$1.15B	$1.02B	$1.04B	$934.24M	$1.08B	$1.11B	$1.01B	$964.86M
Cost of Revenue	$448.18M	$399.95M	$397.73M	$314.58M	$329.37M	$339.48M	$360.37M	$361.32M	$353.19M	$367.85M
Gross Profit	$939.87M	$853.48M	$755.82M	$707.23M	$705.99M	$594.76M	$723.80M	—	$651.62M	$559.51M
Operating Income	$199.39M	$129.05M	-$68.50M	-$76.75M	-$784.0K	-$273.90M	-$171.55M	-$248.07M	$96.49M	$33.45M
Net Income	-$242.47M	$63.23M	$17.55M	-$86.25M	-$135.82M	-$348.82M	-$157.64M	-$189.40M	-$25.09M	-$62.79M
EPS (Diluted)	$-4.45	$1.16	$0.32	$-1.61	$-2.68	$-7.18	$-3.26	$-3.91	$-0.52	$-1.28
Total Assets	$2.61B	$2.51B	$2.43B	$2.29B	$2.20B	$2.40B	$2.41B	$2.55B	$2.50B	$2.34B
Total Liabilities	$1.41B	$1.19B	$1.15B	$1.09B	$906.31M	$1.29B	$1.03B	$1.05B	$688.58M	$635.72M
Shareholders' Equity	$1.20B	$1.32B	$1.28B	$1.21B	$1.29B	$1.11B	$1.38B	$1.50B	$1.82B	$1.71B
Cash & Equivalents	$635.55M	$428.86M	$266.50M	$214.17M	$207.99M	$252.83M	$61.14M	$47.20M	$93.61M	$39.79M
Operating Cash Flow	$254.34M	$183.04M	$74.91M	$69.92M	$102.54M	-$79.42M	-$91.14M	$120.49M	$91.34M	$90.15M
Capital Expenditures	$81.05M	$47.11M	$34.98M	$26.52M	$25.48M	$35.02M	$24.69M	$37.19M	$32.93M	$38.36M
Shares Outstanding	54.65M	54.35M	53.92M	53.56M	53.26M	48.66M	48.44M	48.21M	48.29M	48.03B
Weighted Average Diluted Shares	54.55M	54.57M	54.21M	53.47M	50.63M	48.59M	48.35M	48.50M	48.50M	49.01M
EPS (Basic)	$-4.45	$1.17	$0.33	$-1.61	$-2.68	$-7.18	$-3.21	$-3.91	$-0.52	$-1.29